| CERC Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the CERC market cap history going back to 11/13/2015:
Also see: CERC Shares Outstanding History and CERC YTD Return |
CERC Market Cap History — Cerecor Capitalization Over Time
As of 7/30/2021 Cerecor has a market cap of 255.38 million. Investors often follow the CERC market cap history to compare the size of the company over time.
This page shows CERC market capitalization trends over time, with 26 market cap datapoints presented, dating back to 11/13/2015.
| CERC Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
CERC Historical Market Cap: +41.30% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CERC Stock Price Chart |
| About Avalo Therapeutics Inc |
| Cerecor is a biopharmaceutical company. Co.'s pediatric rare disease pipeline is led by CERC-801, CERC-802 and CERC-803, which are therapies for inherited metabolic disorders known as Congenital Disorders of Glycosylation. Co. is also developing CERC-002, CERC-006 and CERC-007. CERC-007 is an anti-IL-18 monoclonal antibody being developed for the treatment of autoimmune inflammatory diseases such as Adult Onset Stills Disease and Multiple Myeloma. CERC-006 is a dual mTOR inhibitor being developed for the treatment of complex Lymphatic Malformations. CERC-002 is an anti-LIGHT monoclonal antibody being developed for the treatment of Pediatric-onset Crohn's Disease. We show 26 historical shares outstanding datapoints in our CERC shares outstanding history coverage, used to compute CERC market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing CERC market cap history over the course of time is important for investors interested in comparing CERC's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of CERC versus a peer is one thing; comparing CERC market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like CERC can fluctuate over the course of history. With this page we aim to empower investors researching CERC by allowing them to research the CERC market cap history. |
| CERC Current Stock Quote |
Quotes delayed 20 minutes  Free CERC Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: The Importance of Market Cap | |
|
Video: The Importance of Market Cap
| CERC Share Performance |
| Market Cap Peers |
| Cerecor (CERC) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
CERE Market Cap History CERS Market Cap History CFMS Market Cap History CFRX Market Cap History CGEM Market Cap History CGEN Market Cap History CGIX Market Cap History CGON Market Cap History CGTX Market Cap History CHE Market Cap History More Healthcare companies » |
CERC Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
